Clinical Trials on Cluster Seizure in Finland

Total 63 results

University of Oulu

Completed

Antipyretics for Preventing Recurrences of Febrile Seizures

Recurrence of Febrile Seizure

Finland
Kuopio University Hospital

Completed

EEG in In-hospital Patients With Seizure or Altered Mental State

Status Epilepticus | Altered Mental Status | Seizure

Finland
Pfizer

Completed

To Evaluate Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Seizure Disorder, Partial

Spain, France, Italy, Australia, United Kingdom, Germany, Belgium, Netherlands, Austria, Sweden, Finland, South Africa, Switzerland
Johnson & Johnson Pharmaceutical Research & Development...

Completed

Topiramate as Adjunctive Therapy in Infants 1-24 Months for the Control of Partial Onset Seizures

Epilepsy | Seizures | Partial Seizure Disorder

United States, Australia, France, Belgium, Taiwan, Spain, Argentina, Poland, India, Ukraine, Finland, Korea, Republic of, Russian Federation, Chile, Thailand, Hungary, Israel, New Zealand, Canada, Mexico, Norway, Netherlands, South...
Pfizer

Completed

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures.

Seizure Disorder, Partial

United States, Canada
Providence VA Medical Center
University of Alabama at Birmingham; United States Department of Defense; Brown... and other collaborators

Active, not recruiting

Neuroimaging Biomarker for Seizures (NIBMSZS)

Epilepsy | Traumatic Brain Injury | Magnetic Resonance Imaging | Conversion Disorder | Head Injury | Seizure Disorder | Non-Epileptic Seizure | Seizure Disorder, Post Traumatic

United States
National Institute of Neurological Disorders and...

Completed

Neurobiology of Functional Movement Disorder and Non-Epileptic Seizures

Movement Disorders

United States
H. Lundbeck A/S

Completed

A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) (CHRONICLE)

Chronic Cluster Headache

Spain, Germany, United Kingdom, United States, Netherlands, Denmark, Finland, France, Italy
Biohit Oyj
The Finnish Funding Agency for Technology and Innovation (TEKES)

Completed

The Efficacy of L-cysteine in Prevention of Cluster Headache

Cluster Headache

Finland
Eli Lilly and Company

Completed

A Study of LY2951742 (Galcanezumab) in Participants With Cluster Headache

Episodic Cluster Headache | Chronic Cluster Headache

Spain, United States, Finland, Germany, United Kingdom, Belgium, France, Denmark, Italy, Netherlands, Canada, Greece
PulseOn Oy
TAYS Sydänkeskus Oy; Atostek Oy

Completed

Aino ECG Ambulatory Study

Arrhythmias, Cardiac | Atrial Fibrillation and Flutter

Finland
Jazz Pharmaceuticals

Completed

Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures

Epilepsy

United States, Finland
Tampere University

Recruiting

Acute Atrial Fibrillation and Flutter Treated Electively (AFFELECT)

Atrial Fibrillation | Atrial Flutter

Finland
H. Lundbeck A/S

Completed

Eptinezumab in Participants With Episodic Cluster Headache (ALLEVIATE)

Cluster Headache, Episodic

Spain, United States, Germany, Portugal, Italy, Netherlands, Finland, Belgium, Czechia, Denmark, France, Georgia, Russian Federation, United Kingdom, Greece, Estonia, Japan, Norway, Sweden
Eli Lilly and Company

Completed

A Study Of Galcanezumab In Participants With Episodic Cluster Headache

Episodic Cluster Headache

Italy, United States, Canada, Belgium, Denmark, Finland, France, Germany, Spain, United Kingdom, Netherlands, Greece
Eli Lilly and Company

Completed

A Study of Galcanezumab in Participants With Chronic Cluster Headache

Chronic Cluster Headache

United States, Germany, France, Canada, Belgium, Denmark, Finland, Greece, Italy, Netherlands, Spain, United Kingdom
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Study to Evaluate the Efficacy and Safety of TEV-48125 (Fremanezumab) for the Prevention of Episodic Cluster Headache (ECH)

Episodic Cluster Headache

United States, Australia, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom, Canada
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Study Comparing the Efficacy and Safety of Fremanezumab (TEV-48125) for the Prevention of Chronic Cluster Headache (CCH)

Chronic Cluster Headache

United States, Australia, Canada, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom
Kuopio University Hospital
Turku University Hospital

Recruiting

Quantifying the Benefits and Cost-effectiveness of Real-Ear Measurements (REM) for Hearing Aid Fitting (BREM)

Sensorineural Hearing Loss, Bilateral

Finland
Kuopio University Hospital

Terminated

EEG in Resuscitated In-hospital Patients

Seizures | Sudden Cardiac Arrest

Finland
Rhode Island Hospital
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Treatments for Psychogenic Nonepileptic Seizures (NES) (NES)

Depression | Stress Disorders, Post-Traumatic | Conversion Disorder | Convulsion, Non-Epileptic

United States
McGill University Health Centre/Research Institute...
Wayne State University; Brown University; Imperial College London; Ohio State University and other collaborators

Completed

Prospective Research in Infants With Mild Encephalopathy (PRIME)

Brain Injury | Hypoxic-Ischemic Encephalopathy | Neonatal Seizure

Canada, United States, Thailand, United Kingdom
Rhode Island Hospital
Stanford University; University of Cincinnati; American Epilepsy Society; Epilepsy...

Completed

Treatment Trial for Psychogenic Nonepileptic Seizures (NEST-T_1)

Depression | Stress Disorders, Post-Traumatic | Dissociative Disorders | Conversion Disorder | Convulsion, Non-Epileptic

United States
University of Rochester

Terminated

Prophylactic Phenobarbital After Neonatal Seizures (PROPHENO)

Neonatal Seizures

United States
Erasme University Hospital

Recruiting

Sustained Effort Network for Treatment of Status Epilepticus/European Academy of Neurology Registry on Refractory Status Epilepticus (SENSE-II/AROUSE) (SENSEII/AROUSE)

Status Epilepticus

Norway, Switzerland, Finland, Austria, Belgium, Denmark, Germany, United Kingdom
AstraZeneca

Completed

Cardiac Electrophysiological Study

Atrial Flutter

Finland, Norway, Denmark, Sweden
UCB Pharma

Completed

Assess Safety and Efficacy of Lacosamide in Patients With Partial Seizures

Epilepsy

France, Poland, United Kingdom, Germany, Spain, Finland, Australia, Russian Federation, Hungary, Lithuania, Sweden, Czechia, Croatia
Eisai Limited

Terminated

Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures

Epilepsy

Australia, Serbia, Germany, Czech Republic, Romania, Estonia, Lithuania, Croatia, Finland, Hungary, Poland, Russian Federation, Ukraine
Tampere University
VTT Technical Research Centre of Finland; Tays Heart Hospital; GE Healthcare... and other collaborators

Completed

Arrhythmias in Post-Myocardial Infarction Patients

Myocardial Infarction | Coronary Artery Disease | Atrial Fibrillation | Ventricular Fibrillation | Ventricular Tachycardia | Atrioventricular Block | Atrial Flutter | Ventricular Arrythmia | Arrythmia | ECG Electrical Alternans

Finland
Eisai Inc.

No longer available

An Extended Access Program for Perampanel

Partial Onset Seizures

Italy, Spain, Belgium, Israel, Poland, Taiwan, Czechia, Finland, Thailand, Malaysia, Argentina, Chile, Canada, Hungary, Australia, Lithuania, Latvia, Estonia, Netherlands, Greece, Hong Kong
Eisai Inc.

Completed

To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Refractory Partial Seizures

United States, France, Germany, Italy, United Kingdom, Belgium, Israel, South Africa, Finland, Russian Federation, Austria, Netherlands, Sweden, India
Sanofi

Completed

EURopean Trial In Atrial Fibrillation(AF) or Flutter (AFL) Patients Receiving Dronedarone for the maIntenance of Sinus Rhythm (EURIDIS) (EURIDIS)

Atrial Fibrillation | Atrial Flutter

France, Poland, Germany, Italy, Netherlands, Spain, Belgium, Czech Republic, United Kingdom, Denmark, Finland, Hungary
Eisai Inc.

Completed

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

Epilepsy

United States
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pregabalin In Partial Seizures Extension Study (PREPS EXT)

Seizures

France, Finland, Portugal, Poland, Belgium, Switzerland
Eisai Limited

Terminated

Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy

Epilepsy

Australia, Serbia, Germany, Czech Republic, Romania, Estonia, Lithuania, Croatia, Finland, Hungary, Poland, Russian Federation, Ukraine
Pfizer's Upjohn has merged with Mylan to form Viatris...

Completed

Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.

Seizures

Belgium, France, Finland, Poland, Portugal, Switzerland, United Kingdom, Netherlands
Teva Branded Pharmaceutical Products R&D, Inc.

Terminated

A Study to Explore the Long-Term Safety and Efficacy of Fremanezumab (TEV-48125) for the Prevention of Cluster Headache (ENFORCE)

Cluster Headache

United States, Australia, Canada, Finland, Germany, Israel, Italy, Netherlands, Poland, Spain, Sweden, United Kingdom
Biotronik SE & Co. KG

Terminated

European Health Economic Trial on Home Monitoring in ICD and CRT-D Patients (EuroEco) (EuroEco)

Ventricular Fibrillation | Tachycardia, Ventricular | Ventricular Flutter

Spain, Germany, Finland, Belgium, Netherlands, United Kingdom
Eisai Inc.

Completed

4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures

Epilepsy

Belgium, France, United States, Czech Republic, Estonia, Latvia, Spain, United Kingdom, Lithuania, Germany, Australia, Finland, Netherlands, Sweden
UCB Biopharma SRL

Terminated

A Study to Test the Efficacy and Safety of Padsevonil as Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy (DUET)

Drug-Resistant Epilepsy | Focal-Onset Seizures

United States, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Norway, Poland, Portugal, Romania, Serbia, Slovakia, Spain, Sweden, Switzerlan... and more
UCB Biopharma SRL

Terminated

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Drug-Resistant Epilepsy | Focal-Onset Seizures

United States, Australia, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy, Japan, Lithuania, Mexico, Poland, Romania, Serbia, Slovakia, Spain, Turk... and more
Sunovion

Completed

Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs

Epilepsy With Simple or Complex Partial Onset Seizures

United States, Canada
Marinus Pharmaceuticals

Withdrawn

To Evaluate the Efficacy, Safety, and Tolerability of Intravenous Ganaxolone Added to Standard of Care in Refractory Status Epilepticus (RSE)

Refractory Status Epilepticus

Spain, Switzerland, Germany, France, Austria, Italy, Belgium, United Kingdom, Czechia, Croatia, Finland, Lithuania, Israel, Hungary, Poland, Slovakia
Sanofi

Completed

A Trial With Dronedarone to Prevent Hospitalization or Death in Patients With Atrial Fibrillation (ATHENA)

Atrial Fibrillation | Atrial Flutter

United States, Canada, Poland, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Sweden, Turkey, India, Malaysia, Philippines, Singapore, Taiwan, Belgium, Czech Republic, Mexico, Tunisia, Argentina, Finland, Hungary, I... and more
UCB Pharma SA

Completed

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Epilepsy

Belgium, Finland, France, Germany, Hungary, India, Italy, Netherlands, Poland, Spain, Switzerland, United Kingdom
Eisai Inc.

Completed

Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures

Epilepsy

Belgium, Germany, China, Hong Kong, United States, France, Romania, Mexico, South Africa, India, Portugal, Russian Federation, Italy, Canada, Australia, Taiwan, Austria, Malaysia, Hungary, Poland, Thailand, Sweden, Bulgaria, Serbia, Greece and more
UCB Pharma

Completed

A Study of Brivaracetam in Subjects With Partial Onset Seizures

Epilepsy, Focal

France, Poland, United Kingdom, Belgium, Germany, Spain, Czech Republic, Finland, Netherlands
University of Virginia
Medical University of South Carolina; National Institute of Neurological Disorders... and other collaborators

Completed

Established Status Epilepticus Treatment Trial (ESETT)

Benzodiazepine Refractory Status Epilepticus

United States
UCB Pharma

Completed

A Dose-ranging Study With Brivaracetam in Patients From 16 to 65 Years With Refractory Partial Onset Seizures.

Epilepsy

United States, Mexico, India, Brazil
UCB Pharma

Terminated

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

Epilepsy

United States, France, Germany, Spain, Hungary, Italy

Clinical Trials on Cluster Seizure in Finland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Armenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations